Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results

Kevin C. Zorn, Mohamed Bidair, Andrew Trainer, Andrew Arther, Eugene Kramolowsky, Mihir Desai, Leo Doumanian, Dean Elterman, Ronald P. Kaufman, James Lingeman, Amy Krambeck, Gregg Eure, Gopal Badlani, Mark Plante, Edward Uchio, Greg Gin, S. Larry Goldenberg, Ryan Paterson, Alan So, Mitchell Humphreys, Claus Roehrborn, Steven Kaplan, Jay Motola, Naeem Bhojani

Open source

DOI: 10.1002/bco2.121
Published: 2021-10-28
Container: BJUI Compass
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bco2.121,
  title = {Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results},
  author = {Kevin C. Zorn and Mohamed Bidair and Andrew Trainer and Andrew Arther and Eugene Kramolowsky and Mihir Desai and Leo Doumanian and Dean Elterman and Ronald P. Kaufman and James Lingeman and Amy Krambeck and Gregg Eure and Gopal Badlani and Mark Plante and Edward Uchio and Greg Gin and S. Larry Goldenberg and Ryan Paterson and Alan So and Mitchell Humphreys and Claus Roehrborn and Steven Kaplan and Jay Motola and Naeem Bhojani},
  year = {2021},
  journal = {BJUI Compass},
  doi = {10.1002/bco2.121},
  url = {https://doi.org/10.1002/bco2.121}
}

RIS

TY  - JOUR
TI  - Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
AU  - Kevin C. Zorn
AU  - Mohamed Bidair
AU  - Andrew Trainer
AU  - Andrew Arther
AU  - Eugene Kramolowsky
AU  - Mihir Desai
AU  - Leo Doumanian
AU  - Dean Elterman
AU  - Ronald P. Kaufman
AU  - James Lingeman
AU  - Amy Krambeck
AU  - Gregg Eure
AU  - Gopal Badlani
AU  - Mark Plante
AU  - Edward Uchio
AU  - Greg Gin
AU  - S. Larry Goldenberg
AU  - Ryan Paterson
AU  - Alan So
AU  - Mitchell Humphreys
AU  - Claus Roehrborn
AU  - Steven Kaplan
AU  - Jay Motola
AU  - Naeem Bhojani
PY  - 2021
JO  - BJUI Compass
DO  - 10.1002/bco2.121
UR  - https://doi.org/10.1002/bco2.121
ER  -

APA

Zorn, K. C., Bidair, M., Trainer, A., Arther, A., Kramolowsky, E., Desai, M., Doumanian, L., Elterman, D., Kaufman, R. P., Lingeman, J., Krambeck, A., Eure, G., Badlani, G., Plante, M., Uchio, E., Gin, G., Goldenberg, S. L., Paterson, R., So, A., Humphreys, M., Roehrborn, C., Kaplan, S., Motola, J., & Bhojani, N. (2021). Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results. BJUI Compass. https://doi.org/10.1002/bco2.121

Source records

crossref · retrieved 2026-09-26T06:19:22.911Z